Foundations Investment Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History
Foundations Investment Advisors, LLC
- $3.58 Billion
- Q1 2024
A detailed history of Foundations Investment Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Foundations Investment Advisors, LLC holds 38,976 shares of RXRX stock, worth $292,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,976
Previous 73,658
47.09%
Holding current value
$292,320
Previous $726,000
46.56%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding RXRX
# of Institutions
259Shares Held
192MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$184 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$181 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$120 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$92.4 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$78 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.35B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...